BRKRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BRKRP
BRUKER CORP
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$55.37+0.57 (+1.04%)
Close on Oct 19, 2026
- Market cap
- $8.43B
- P/E (TTM)
- –
- Dividend yield
- –
BRUKER CORP revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSI CALID | $310.30M | $316.30M | $331.60M | $312.70M | $285.80M | $280.10M | $320.60M | $279.40M | $265.60M | $227.90M | – | – | 37.0% | +8.6% |
| BSI NANO | $261.30M | $246.00M | $309.10M | $266.50M | $252.10M | $256.60M | $318.30M | $287.10M | $252.50M | $240.40M | – | – | 31.2% | +3.6% |
| BSI BioSpin | $195.70M | $197.50M | $267.00M | $208.70M | $195.30M | $207.80M | $272.40M | $233.00M | $217.50M | $182.80M | – | – | 23.3% | +0.2% |
| BEST | $74.20M | $66.80M | $71.50M | $73.80M | $66.30M | $59.30M | $72.10M | $68.70M | $69.10M | $73.10M | $75.20M | $70.60M | 8.8% | +11.9% |
| BSI BioSpin | – | – | – | – | – | – | – | $233.00M | $217.50M | $182.80M | – | $198.30M | – | – |
| Bruker NANO | – | – | – | – | – | – | – | $287.10M | $252.50M | $240.40M | – | $238.70M | – | – |
| Bruker CALID | – | – | – | – | – | – | – | $279.40M | $265.60M | $227.90M | – | $239.30M | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments and Reconciling Items | $183.90M | $74.10M | – | – | $60.00M | $70.00M | – | – | – | – | – | – | +206.5% |
| BSI CALID | $72.30M | $62.60M | $71.70M | $76.00M | $53.30M | $61.50M | $78.00M | $58.70M | $58.40M | $51.10M | $80.50M | $50.00M | +35.6% |
| BSI BioSpin | $41.70M | $28.80M | $63.00M | $33.30M | $23.10M | $37.10M | $78.60M | $56.80M | $46.60M | $34.60M | $87.50M | $52.50M | +80.5% |
| BSI NANO | $29.80M | $14.40M | $45.10M | $23.50M | $9.40M | $23.10M | $44.10M | $30.60M | $19.20M | $29.80M | $58.70M | $39.00M | +217.0% |
| BEST | $7.60M | $7.60M | $5.50M | $7.00M | $7.20M | $7.00M | $8.60M | $7.70M | $10.60M | $8.20M | $4.40M | $9.00M | +5.6% |
| Unallocated Expenses | – | – | $77.20M | $157.60M | $60.00M | $70.00M | $105.50M | $61.00M | $62.40M | $35.80M | – | – | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $663.70M | $646.40M | $797.30M | $691.10M | $634.70M | $643.30M | $808.60M | $709.30M | $654.40M | $586.90M | $715.80M | $615.10M | 79.2% | +4.6% |
| Service and other revenue | $174.80M | $177.00M | $179.90M | $169.40M | $162.70M | $158.10M | $171.00M | $155.10M | $146.30M | $134.80M | $138.70M | $127.70M | 20.8% | +7.4% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $248.20M | $221.90M | $225.00M | $226.00M | $222.90M | $217.40M | $261.00M | $239.00M | $243.70M | $194.80M | $212.20M | $211.10M | 29.6% | +11.4% |
| Europe excluding Germany | $244.30M | $258.90M | $271.50M | $241.20M | $213.40M | $224.10M | $287.00M | $215.60M | $192.30M | – | – | – | 29.1% | +14.5% |
| Asia Pacific excluding China | $112.40M | $134.70M | $163.10M | $130.70M | $127.40M | $131.40M | $164.20M | $141.10M | $106.20M | – | – | – | 13.4% | -11.8% |
| China | $104.90M | $74.00M | $138.10M | $121.80M | $114.70M | $101.20M | $113.80M | $121.30M | $120.40M | $115.70M | $167.30M | $136.70M | 12.5% | -8.5% |
| Germany | $64.40M | $62.70M | $105.50M | $71.30M | $59.10M | $61.10M | $86.10M | $74.30M | $83.50M | $66.80M | $79.40M | $78.00M | 7.7% | +9.0% |
| Other | $64.30M | $71.20M | $74.00M | $69.50M | $59.90M | $66.20M | $67.50M | $73.10M | $54.60M | $59.30M | $62.00M | $50.40M | 7.7% | +7.3% |
| Rest of Europe | – | – | – | – | – | $224.10M | $287.00M | $215.60M | $192.30M | $178.10M | $204.70M | $174.00M | – | – |
| Rest of Asia Pacific | – | – | – | – | – | $131.40M | $164.20M | $141.10M | $106.20M | $107.00M | $128.90M | $92.60M | – | – |
From the segment and revenue-disaggregation notes of Bruker's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.